Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Jan;93(1):78-84.
doi: 10.1111/j.1349-7006.2002.tb01203.x.

Functional mimicry of an anti-idiotypic antibody to nominal antigen on cellular response

Jie Ma  1 , Liqiang Zhou, Daqing Wang
Affiliations

Functional mimicry of an anti-idiotypic antibody to nominal antigen on cellular response

Jie Ma et al. Jpn J Cancer Res. 2002 Jan.

Abstract

One concept for immune therapy of cancer involves induction of antigen mimic antibodies to trigger the immune system into a response against the tumor cells. Anti-idiotypic antibodies (Ab2) directed against the antigen-combining site of other antibodies (Ab1) may functionally and even structurally mimic antigen and induce anti-anti-idiotypic immune response. We report here the generation of murine monoclonal antibody (mAb) WJ02 (Ab2) raised against the murine monoclonal immunoglobulin MJ01 (Ab1), which defines ovarian cancer antigen CA125. In enzyme immunoassays the binding of Ab2 to the variable region of Ab1 could be inhibited by CA125. In addition, the mimicry of mAb WJ02 to CA125 on cellular immune response was detected by human peripheral blood cells. The T cells primed by mAb WJ02 or CA125 proliferated in the presence of CA125 or mAb WJ02, respectively. Furthermore, T cells specific to mAb WJ02 could lyse ovarian cancer cells OVCAR-3 that express CA125. Finally, we proved that a patient immunized with mAb MJ01 could induce T cells that recognize mAb WJ02. In summary, we conclude that mAb WJ02 mimics CA125 on cellular response and such functional mimicry is one of the most important criteria to select Ab2 for cancer therapy.

PubMed Disclaimer

References

    1. ) Raychaudhuri , S. , Saeki , Y. , Fuji , H. and Kohler , H.Tumor‐specific idiotype vaccines I. Generation and characterization of internal image tumor antigen . J. ImmunoL. , 137 , 1743 – 1749 ( 1986. ). - PubMed
    1. ) Herlyn , D. , Wettendorff , M. , Iliopoulos , D. and Koprowski , H.Functional mimicry of tumor‐associated antigens by antiidiotypic antibodies . Exp. Clin. Immunogenet. , 5 , 165 – 175 ( 1988. ). - PubMed
    1. ) Baum , R. P. , Niesen , A. , Hertel , A. , Nancy , A. , Hess , H. , Donnerstag , B. , Sykes , T. R. , Sykes , C. J. , Suresh , M. R. , Noujaim , A. A. and Hor , G.Activating anti‐idiotypic human anti‐mouse antibodies for immunotherapy of ovarian cancer . Cancer , 73 , 1121 – 1125 ( 1994. ). - PubMed
    1. ) Kasai , Y. , Herlyn , D. , Sperlagh , M. , Maruyama , H. , Matsushita , S. and Linnenbach , A. J.Molecular cloning of murine monoclonal anti‐idiotypic Fab . J. Immunol. Methods , 155 , 77 – 89 ( 1992. ). - PubMed
    1. ) Losman , M. J. , Novick , K. E. , Goldenberg , D. M. and Monestier , M.Mimicry of a carcinoembryonic antigen epitope by a rat monoclonal anti‐idiotype antibody . Int. J. Cancer , 56 , 580 – 584 ( 1994. ). - PubMed

Publication types

MeSH terms